高级检索
当前位置: 首页 > 详情页

Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Pharmaceutics, Shenyang Pharmaceutical University, WenhuaRoad 103, Shenyang 110016 [2]Department of Stomatology, The Fourth Hospital of Hebei Medical University, Jiankang Road 12, Shijiazhuang 050011 [3]New Drug Research and Development Center, North China Pharmaceutical Group Corporation, Heping East Road 388, Shijiazhuang 050015, P.R. China
出处:
ISSN:

关键词: matrix metalloproteinase 2 tissue inhibitor of metalloproteinase 2 squamous cell carcinoma

摘要:
The aim of this study is to investigate the expression of matrix metal loproteinase 2 (MMP-2) and the tissue inhibitor of metal loproteinase 2 (TIMP-2) in oral squamous cell carcinoma (OSCC) and adjacent normal tissues, and explore the role of MMP-2 and TIMP-2 in carcinoma metastasis and invasion. Expression of MMP-2 and TIMP-2 was evaluated in 40 cases with semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemical techniques. The values of MMP-2/ beta-actin and TIMP-2/beta-actin in OSCC were significantly higher than those in adjacent normal tissues 2 cm and >= 5 cm from carcinoma tissues (p < 0.05). The results of immuno-histochernical analysis show that the positive expression of MMP-2 and TIMP-2 protein in tumor tissues (60.0 and 52.5%) was higher than that in adjacent normal tissues 2 cm (30.0 and 22.5%) and 5 cm (22.5 and 25.0%) from cancer tissues, and the difference was significant (p < 0.05). The expression of MMP-2 and TIMP-2 was related to the differentiation degree of tumor cells, metastatic lymph node status and stage of carcinoma, but not related to the age and gender of patients, or location of the carcinoma. Therefore, MMP-2 and TIMP-2 may play important roles in the invasion and metastasis of OSCC.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2005]版:
大类 | 3 区 医学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验
JCR分区:
出版当年[2005]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2005版] 出版当年五年平均 出版前一年[2004版] 出版后一年[2006版]

第一作者:
第一作者机构: [1]Department of Pharmaceutics, Shenyang Pharmaceutical University, WenhuaRoad 103, Shenyang 110016
通讯作者:
通讯机构: [1]Department of Pharmaceutics, Shenyang Pharmaceutical University, WenhuaRoad 103, Shenyang 110016 [*1]Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号